Local

FDA panel endorses new Alzheimer’s disease treatment

ORLANDO, Fla. — Food and Drug Administration advisors have voted to endorse an Alzheimer’s drug from Eli Lilly.

WATCH CHANNEL 9 EYEWITNESS NEWS

The FDA panel agreed this week that the drug is safe and effective.

It’s a monoclonal antibody designed to slow the progression of early stages of Alzheimer’s disease.

Read: ‘It’s not an easy journey’: Woman diagnosed with early-onset Alzheimer’s strives for positive life

If approved, this would be the second drug on the market with those intended effects.

Click here to download our free news, weather and smart TV apps. And click here to stream Channel 9 Eyewitness News live.

0
Comments on this article
0